Independent Directors' Special Meeting Eleventh Session Review Opinion

Maple Medical Co., Ltd.·June 16, 2026·3 pages

✨ AI Summary

The independent directors reviewed the proposed adjustments to the share issuance and cash payment for asset acquisition plan. They concluded the adjustments comply with relevant laws and regulations, are reasonable and feasible, and do not harm shareholder interests. The directors approved submitting the proposal to the board.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Independent Directors' Special Meeting Review Opinion

Guangzhou V-V Medical Technology Co., Ltd. Third Board of Directors Independent Directors' Special Meeting Eleventh Session Review Opinion

Guangzhou V-V Medical Technology Co., Ltd. (hereinafter referred to as "the Company" or "the Listed Company") intends to acquire 100% equity of Guangzhou Yi-Jia Medical Technology Co., Ltd. (hereinafter referred to as "the Target Company" or "Yi-Jia Medical") held by 10 counterparties including Guangzhou Ze-Xin Medical Technology Co., Ltd. and Guangzhou Yi-Chuang Investment Partnership (Limited Partnership) through share issuance and cash payment, and raise supporting funds (hereinafter referred to as "this Transaction").

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.